ľֱ

Wearable Potassium Monitor; Rheumatic Valve Disease Dilemma; BP in the VA

— Recent developments of interest in cardiovascular medicine

MedpageToday

The FDA gave AliveCor breakthrough device designation for an , similar to arrhythmia detection with its wearables. (TechCrunch)

One of the most is associated with a more than twofold risk of aortic aneurysm or aortic dissection. (Cardiovascular Business)

The New York Times on the desperate situation of by rheumatic fever from untreated strep throat.

Barbershop blood pressure-monitoring pioneer , of Cedars-Sinai in Los Angeles, has died, the institution announced.

One in seven older adults in the VA system had their during an admission for non-cardiac conditions, more than half of whom had already well-controlled blood pressure -- suggesting overtreatment. (BMJ)

The FDA cleared the for treating acute coronary artery perforations. (Rare Disease Report)

The agency also cleared for parsing data from wearable biosensors.

The , developed in China, was on par with Xience for safety and efficacy in a European trial appearing in The Lancet. (PR Newswire)

are four times more likely to die in hospital if they have central sleep apnea, researchers reported in the Journal of Clinical Sleep Medicine.

Two of Medtronic's cardiac rhythm device manufacturing plants, in Minnesota and Puerto Rico, got over design and production process deficiencies.